CULTIVARIUM · RADIO
← On air
Mito Hour

Plant Nanovesicles Target Mitochondria Via Peptide

Mito Hour · with Theo & Dr. Mara · Recorded Aug 9, 2026
More episodes → Share on X Read the paper →
Transcript

[THEO] Okay, picture this. You've got a tiny bubble of fat squeezed out of a goji berry, and you slap a little address label on the outside so it knows to go find your bones. That's roughly the paper we're chewing on today.

[DR. MARA] Roughly. Though I'd hold the enthusiasm until we talk about what "went to the mitochondria" actually shows. But yes — the vehicle here is a plant-derived vesicle-like nanoparticle, from Lycium barbarum, the goji berry.

[THEO] And before we get to the goji part — Mara, why would anyone care about getting cargo into mitochondria specifically? We're Mito Hour, so let's earn it.

[DR. MARA] The mitochondrion runs oxidative phosphorylation — the electron transport chain pumping protons across the inner membrane, ATP synthase spinning that gradient back into ATP. It's the cell's main power plant. If a cell's metabolism is skewed the wrong way, toward glycolysis say, and you want to push it back toward oxidative phosphorylation, the mitochondrion is where you'd intervene. The trouble is delivery. It's a double-membraned organelle buried inside the cell. Getting a molecule to it, on purpose, is hard.

[THEO] Right, it's not just one wall, it's a wall inside a wall inside a cell inside a body. So people have been using extracellular vesicles as delivery trucks. These are the little membrane-wrapped packets cells naturally shed. Plants make analogous things — that's the "vesicle-like nanoparticle."

[DR. MARA] And plant-derived ones are attractive because they're cheap to source, low toxicity, and you can get a lot of them. The catch is targeting. A raw vesicle goes wherever it goes. So the question this group asked: can we steer it?

[THEO] Here's the trick I actually love. To put an address label on the surface, they used a lipid called DSPE-PEG2000. Think of it as a little grappling hook with a greasy tail and a flexible tether. The greasy tail — that's the DSPE, a phospholipid — just slots itself into the vesicle's own membrane. Hydrophobic insertion. Oil likes oil.

[DR. MARA] It's a physical anchoring, no chemistry required on the vesicle itself. And on the other end of that PEG tether they hung a peptide, SDSSD, which has affinity for bone — specifically it homes to bone marrow stromal cells, BMSCs. That's the address.

[THEO] So how'd they make the vesicles in the first place?

[DR. MARA] Standard fractionation. Differential centrifugation to clear debris, then ultracentrifugation at 150,000 g through a sucrose gradient — 8, 30, 45, 60 percent — to band the vesicles by density. They characterized them, tracked particle size and number by nanoparticle tracking analysis, ran lipidomics on the composition.

[THEO] And then the surprise. Once these decorated vesicles got into the BMSCs, they didn't just diffuse everywhere — they showed a real preference for landing at the mitochondria.

[DR. MARA] A propensity, yes. I want to be precise: colocalization with mitochondria, a distinct tendency. And the cargo mattered. They loaded a plant microRNA, miR167a-5p — a small regulatory RNA from the plant itself — which they report directly targets SLC25A26.

[THEO] Which is a mitochondrial carrier gene, right? One of the proteins that shuttles metabolites across the mitochondrial membrane.

[DR. MARA] SLC25A26 imports S-adenosylmethionine into the mitochondrion. Knock its message down with the miRNA, and they saw the cell's metabolism shift toward oxidative phosphorylation. So the vesicle delivered a regulator that reached into mitochondrial function.

[THEO] A goji-berry bubble, wearing a bone-seeking address label, dropping a plant microRNA that retunes the power plant. That's a lot of moving parts working together.

[DR. MARA] It's an elegant demonstration of surface engineering by hydrophobic insertion. What I'd want next is the mechanism of that mitochondrial homing — why the organelle — and harder controls on the metabolic shift. But as a delivery concept, it's genuinely clever.

[THEO] And on that note — we'll hand it back to the studio. Stay tuned.